ERBITUX® Followed by Adjuvant Treatment With Chemoradiation and ERBITUX® for Locally Advanced Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Cetuximab
Related studies linked through entity extraction aliases.
Selumetinib and Cetuximab in Treating Patients With Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Cetuximab Plus Radiotherapy Versus Cisplatin Plus Radiotherapy in Locally Advanced Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Adenoid Cystic Carcinoma, Erbitux, and Particle Therapy
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Cetuximab and Simvastatin in Treating Patients With Advanced or Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Trial to Determine the Safety and Anti-tumor Activity Profile of the Combination of Cetuximab and Concomitant Cisplatin Plus 5-Fluorouracil (5-FU) in Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma in Head and Neck
- Status
- COMPLETED
- Phase
- PHASE3
Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Lenalidomide and Cetuximab in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of BIBW 2992 (Afatinib) in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
An Observational Study to Evaluate the Safety and Efficacy of Cetuximab in Combination With Platinum-based Chemotherapy in the First-line Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
- Status
- TERMINATED
- Phase
- N/A
An Observational Study to Evaluate the Safety and Efficacy of FOLFIRI / FOLFOX Plus Cetuximab as First-line Therapy in Patients With KRAS Wild-type Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- N/A
Lenalidomide and Cetuximab in Treating Patients With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE3
Re-irradiation With Fractionated Stereotactic Radiosurgery Plus Cetuximab in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE2
Study in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Neo-Adjuvant Study in Triple Negative Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Trial of BIBW 2992 (Afatinib) + Cetuximab in Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1